Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (1) Hinz, Michael Dr. (3) Janz, Martin Dr. (10) Kirchner, Marieluise Dr. (2) Landthaler, Markus Prof. Dr. (1) Lusatis, Simone (1) Pombo, Ana Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (4) Stein, Ulrike Prof. Dr. (1) Walther, Wolfgang Prof. Dr. (1) Wollert-Wulf, Brigitte (2) Wyler, Emanuel Dr. (1) (-) Mathas, Stephan Dr. (11) (-) Selbach, Matthias Prof. Dr. (10) (-) Biologie maligner Lymphome (11) Epigenetische Regulation und Chromatinstruktur (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Proteom Dynamik (10) RNA Biologie und Posttranscriptionale Regulation (1) 1999 (3) 2000 (1) 2001 (4) (-) 2002 (8) (-) 2003 (2) 2004 (4) 2005 (6) (-) 2006 (6) 2007 (4) 2008 (7) 2009 (9) 2010 (6) 2011 (11) (-) 2012 (5) 2013 (5) 2014 (14) 2015 (15) 2016 (10) 2017 (9) 2018 (7) 2019 (6) 2020 (8) 2021 (15) 2022 (14) 2023 (12) 2024 (3) 21 Ergebnisse: Active Filter: Mathas, Stephan Dr.Selbach, Matthias Prof. Dr.Biologie maligner LymphomeProteom Dynamik2002200320062012 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Juni 2012 / Mol Cell Proteomics Proteomic analysis of mitotic RNA polymerase II reveals novel interactors and association with proteins dysfunctional in disease A. Moeller S.Q. Xie F. Hosp B. Lang H.P. Phatnani S. James F. Ramirez G.B. Collin J.K. Naggert M.M. Babu A.L. Greenleaf M. Selbach A. Pombo 01. August 2012 / Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas 07. Mai 2012 / Methods Mol Biol In vivo quantitative proteome profiling: planning and evaluation of SILAC experiments M. Kirchner M. Selbach 08. Juni 2012 / Mol Cell The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts A.G. Baltz M. Munschauer B. Schwanhaeusser A. Vasile Y. Murakawa M. Schueler N. Youngs D. Penfold-Brown K. Drew M. Milek E. Wyler R. Bonneau M. Selbach C. Dieterich M. Landthaler 29. Juni 2012 / PLoS ONE In vivo conditions to identify prkci phosphorylation targets using the analog-sensitive kinase method in zebrafish E. Cibrian Uhalte M. Kirchner N. Hellwig J.J. Allen S. Donat K.M. Shokat M. Selbach S. Abdelilah-Seyfried 01. August 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit 01. August 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken 01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken 01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou 02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. Juni 2012 / Mol Cell Proteomics Proteomic analysis of mitotic RNA polymerase II reveals novel interactors and association with proteins dysfunctional in disease A. Moeller S.Q. Xie F. Hosp B. Lang H.P. Phatnani S. James F. Ramirez G.B. Collin J.K. Naggert M.M. Babu A.L. Greenleaf M. Selbach A. Pombo
01. August 2012 / Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas
07. Mai 2012 / Methods Mol Biol In vivo quantitative proteome profiling: planning and evaluation of SILAC experiments M. Kirchner M. Selbach
08. Juni 2012 / Mol Cell The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts A.G. Baltz M. Munschauer B. Schwanhaeusser A. Vasile Y. Murakawa M. Schueler N. Youngs D. Penfold-Brown K. Drew M. Milek E. Wyler R. Bonneau M. Selbach C. Dieterich M. Landthaler
29. Juni 2012 / PLoS ONE In vivo conditions to identify prkci phosphorylation targets using the analog-sensitive kinase method in zebrafish E. Cibrian Uhalte M. Kirchner N. Hellwig J.J. Allen S. Donat K.M. Shokat M. Selbach S. Abdelilah-Seyfried
01. August 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit
01. August 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken
01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken
01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou
02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit